POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) has been given a consensus recommendation of “Hold” by the ten research firms that are currently covering the stock, Marketbeat.com reports. Ten research analysts have rated the stock with a hold rating. The average 12-month target price among brokerages that have updated their coverage on the […]
Shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) have received a consensus rating of “Hold” from the ten analysts that are covering the firm, MarketBeat Ratings reports. Ten analysts have rated the stock with a hold recommendation. The average 12 month price objective among analysts that have updated their coverage on the […]